Dermatomyositis
📧 Sign up to get email alerts when something new happens for Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-24Clinical Trial Update: Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis [Phase 2]
A Phase 2 study of deucravacitinib for refractory dermatomyositis and juvenile dermatomyositis has been withdrawn. The trial was sponsored b…
-
CLINICAL_TRIALS withdrawal · 2025-07-17Clinical Trial Update: Study of M5049 in DM and PM Participants (NEPTUNIA) [Phase 2]
A Phase 2 trial (NEPTUNIA) evaluating M5049 for Dermatomyositis and Polymyositis has been terminated.